首页> 美国卫生研究院文献>other >Bone lead (Pb) content at the tibia is associated with thinner distal tibia cortices and lower volumetric bone density in postmenopausal women
【2h】

Bone lead (Pb) content at the tibia is associated with thinner distal tibia cortices and lower volumetric bone density in postmenopausal women

机译:绝经后妇女胫骨中的骨铅(Pb)含量与胫骨远端皮质变薄和体积骨密度降低相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Conflicting evidence suggests that bone lead or blood lead may reduce areal bone mineral density (BMD). Little is known about how lead at either compartment affects bone structure. This study examined postmenopausal women (N = 38, mean age 76 ± 8, body mass index (BMI): 26.74 ± 4.26 kg/m2) within the Hamilton cohort of the Canadian Multicentre Osteoporosis Study (CaMos), measuring bone lead at 66% of the non-dominant leg and at the calcaneus using 109Cadmium X-ray fluorescence. Volumetric BMD and structural parameters were obtained from peripheral quantitative computed tomography images (200 μm in-plane resolution, 2.3 ± 0.5 mm slice thickness) of the same 66% site and of the distal 4% site of the tibia length. Blood lead was measured using atomic absorption spectrometry and blood-to-bone lead partition coefficients (PBB, log ratio) were computed. Multivariable linear regression examined each of bone lead at the 66% tibia, calcaneus, blood lead and PBB as related to each of volumetric BMD and structural parameters, adjusting for age and BMI, diabetes or antiresorptive therapy. Regression coefficients were reported along with 95% confidence intervals. Higher amounts of bone lead at the tibia were associated with thinner distal tibia cortices (−0.972 (−1.882, −0.061) per 100 μg Pb/g of bone mineral) and integral volumetric BMD (−3.05 (−6.05, −0.05) per μg Pb/g of bone mineral). A higher PBB was associated with larger trabecular separation (0.115 (0.053, 0.178)), lower trabecular volumetric BMD (−26.83 (−50.37, −3.29)) and trabecular number (−0.08 (−0.14, −0.02)), per 100 μg Pb/g of bone mineral after adjusting for age and BMI, and remained significant while accounting for diabetes or use of antiresorptives. Total lead exposure activities related to bone lead at the calcaneus (8.29 (0.11, 16.48)) and remained significant after age and antiresorptives-adjustment. Lead accumulated in bone can have a mild insult on bone structure; but greater partitioning of lead in blood versus bone revealed more dramatic effects on both microstructure and volumetric BMD.
机译:有矛盾的证据表明,骨铅或血铅可能会降低面骨矿物质密度(BMD)。关于任一隔间的铅如何影响骨骼结构的知之甚少。这项研究调查了加拿大多中心骨质疏松研究(CaMos)汉密尔顿队列中的绝经后妇女(N = 38,平均年龄76±8,体重指数(BMI):26.74±4.26 kg / m 2 ) ),使用 109 Cd X射线荧光法测量非显性腿和跟骨66%的骨铅。体积BMD和结构参数是从胫骨长度相同的66%部位和远端4%部位的外周定量计算机断层扫描图像(200μm平面内分辨率,2.3±0.5 mm切片厚度)获得的。使用原子吸收光谱法测量血铅,并计算血骨铅分配系数(PBB,对数比)。多变量线性回归检查了每个骨铅在66%胫骨,跟骨,血铅和PBB中的含量,它们与每个体积BMD和结构参数有关,并针对年龄和BMI,糖尿病或抗吸收疗法进行了调整。报告了回归系数以及95%置信区间。胫骨中较高的骨铅含量与较薄的胫骨远端皮质(每100μgPb / g骨矿物质-0.972(-1.882,-0.061))和整体体积BMD(-3.05(-6.05,-0.05)微克铅/克骨矿物质)。每100个PBB越高,骨小梁间距越大(0.115(0.053,0.178)),骨小梁容积BMD越低(−26.83(−50.37,-3.29))和骨小梁数(−0.08(-0.14,-0.02))在调整了年龄和BMI之后,μgPb / g骨矿物质,并且在考虑糖尿病或使用抗吸收剂时仍然很显着。跟骨骨铅相关的总铅暴露活动(8.29(0.11,16.48)),并在年龄和抗吸收剂调整后仍显着。骨骼中积累的铅会对骨骼结构产生轻微伤害;但是,血液中的铅与骨骼中的铅相比,分配更大,对微观结构和体积骨密度都有显着影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号